Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage [Phase 1]

View source ↗

Summary

This is a Phase 1 pharmacokinetic study evaluating Hemay005 tablets in subjects with psoriasis to assess how liver damage affects drug exposure. The trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: RECRUITING